Matthias Aizenberg

The biological mystery of why two women with the exact same genetic mutation face drastically different health outcomes remains one of the most pressing questions in modern oncology. While the presence of a BRCA1 mutation is often viewed as a definitive roadmap for a patient’s future, the actual

The rapid advancement of biotechnology across the African continent has created an urgent demand for a new generation of policy experts capable of managing complex biological risks while fostering scientific innovation. To meet this critical need, the School of Public Health’s Pandemic Center has

Ivan Kairatov stands at the intersection of biopharmaceutical innovation and clinical technology, bringing years of expertise in research and development to the forefront of oncology care. His work focuses on bridging the gap between raw medical data and actionable clinical insights, particularly

Physicians have long understood that the subtle dance of blood through a human heart cannot be captured by static imagery alone, yet the tools required to measure this flow have remained stubbornly invasive until now. For decades, the gold standard for diagnosing coronary obstructions involved

The official ribbon-cutting ceremony at Kitimat General Hospital on March 27, 2026, marked a transformative shift in rural healthcare delivery for the residents of the North Coast. For years, the community anticipated the arrival of local Computed Tomography imaging, a technological gap that often

The digital fabrication of human anatomy has progressed from a niche computational experiment into a sophisticated radiological reality that challenges the very foundation of clinical evidence. Synthetic medical imaging, often termed "deepfake" radiology, no longer requires deep expertise in

Ivan Kairatov is a leading figure in the biopharmaceutical landscape, recognized for his extensive contributions to the research and development of implantable medical technologies. With a career spanning the intersection of materials science and biotechnology, he has dedicated his expertise to

The pharmaceutical industry is currently witnessing a profound shift as researchers move away from traditional two-dimensional cell cultures toward complex three-dimensional architectures that more accurately reflect the intricate physiological environment of the human body. This transition is

The publication of Volume 36 of SLAS Technology represents a watershed moment for the global scientific community, effectively bridging the gap between theoretical engineering and practical biological application. This latest volume serves as a comprehensive roadmap for the next era of intelligent

Ivan Kairatov is a leading biopharma expert with a profound background in molecular oncology and therapeutic innovation. His extensive research in drug development has centered on the complex interplay between tumor biology and the microenvironment, particularly how cellular communication drives